Insider · CIK 0001328146

Kiener Peter A

Reports to the SEC for 5 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001328146

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+24.4K sh	—	—	24,400
2025-11-13	LAVA Therapeutics NVShare Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−33.4K sh	—	—	0
2025-02-13	LAVA Therapeutics NVCommon Shares (Right to Buy)A Award	Director	AAward	+33.4K sh	—	—	33,390
2025-01-02	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+24.4K sh	—	—	24,400
2024-01-02	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+24.4K sh	—	—	24,400
2023-06-21	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-03-23	CUECue Biopharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,682 sh	—	—	96,062
2023-03-23	CUECue Biopharma, Inc.S Sale	Director	SSale	−9,325 sh	$3.28	−$30.6K	357
2023-03-23	CUECue Biopharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,682 sh	$2.86	+$27.7K	9,682
2023-01-03	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2022-06-22	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2022-01-03	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-11-16	CUECue Biopharma, Inc.S Sale	Director	SSale	−1,361 sh	$18.02	−$24.5K	0
2021-11-16	CUECue Biopharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,361 sh	$2.86	+$3,892.46	1,361
2021-11-16	CUECue Biopharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,361 sh	—	—	105,744
2021-11-15	CUECue Biopharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+18.8K sh	$2.86	+$53.8K	18,815
2021-11-15	CUECue Biopharma, Inc.S Sale	Director	SSale	−18.8K sh	$17.92	−$337K	0
2021-11-15	CUECue Biopharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−18.8K sh	—	—	107,105
2021-06-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-01-04	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-06-23	PVLAPALVELLA THERAPEUTICS, INC. · Stock Options (Right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-01-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-01-02	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2019-01-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2019-01-02	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2018-10-24	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2018-06-12	CUECue Biopharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+9,600 sh	—	—	9,600
2018-02-13	Sucampo Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Science Officer	DDisposition to Issuer	−133K sh	$6.15	−$818K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.D Disposition to Issuer	Chief Science Officer	DDisposition to Issuer	−44.9K sh	$18.00	−$807K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Science Officer	DDisposition to Issuer	−87.2K sh	$4.20	−$366K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Science Officer	DDisposition to Issuer	−38.5K sh	$3.18	−$122K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Science Officer	DDisposition to Issuer	−250K sh	$9.67	−$2.42M	0
2017-12-31	Sucampo Pharmaceuticals, Inc.A Award	Chief Science Officer	AAward	+329 sh	$9.10	+$2,993.9	44,856
2017-12-28	Sucampo Pharmaceuticals, Inc.F Tax Payment	Chief Science Officer	FTax Payment	−27.5K sh	$17.98	−$494K	44,527
2017-12-07	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Chief Science Officer	MExercise/Conversion	+50K sh	$8.33	+$417K	52,023
2017-12-07	Sucampo Pharmaceuticals, Inc.S Sale	Chief Science Officer	SSale	−50K sh	$16.50	−$825K	2,023
2017-12-07	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Science Officer	MExercise/Conversion	−50K sh	—	—	242,567
2017-09-30	Sucampo Pharmaceuticals, Inc.A Award	Chief Science Officer	AAward	+330 sh	$9.10	+$3,003	2,023
2017-06-30	Sucampo Pharmaceuticals, Inc.A Award	Chief Science Officer	AAward	+336 sh	$8.93	+$3,000.48	1,693
2017-03-31	Sucampo Pharmaceuticals, Inc.A Award	Chief Science Officer	AAward	+321 sh	$9.35	+$3,001.35	1,357
2017-03-06	Sucampo Pharmaceuticals, Inc.A Award	Chief Science Officer	AAward	+70K sh	—	—	70,000
2017-03-06	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Chief Science Officer	AAward	+133K sh	—	—	626,270
2016-12-31	Sucampo Pharmaceuticals, Inc.A Award	Chief Science Officer	AAward	+287 sh	$10.46	+$3,002.02	1,036
2016-09-30	Sucampo Pharmaceuticals, Inc.A Award	Chief Science Officer	AAward	+320 sh	$9.38	+$3,001.6	749
2016-06-30	Sucampo Pharmaceuticals, Inc.A Award	Chief Science Officer	AAward	+300 sh	$9.32	+$2,796	429
2016-03-31	Sucampo Pharmaceuticals, Inc.A Award	Chief Science Officer	AAward	+129 sh	$9.29	+$1,198.41	129
2016-03-02	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Chief Science Officer	AAward	+116K sh	—	—	493,270
2015-03-04	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Chief Science Officer	AAward	+77K sh	—	—	377,000

Recent filings

Accepted (ET)
Jan 64
Kiener Peter A0001193125-26-004359
SEC(opens sec.gov)
Nov 174
Kiener Peter A0001328146-25-000004
SEC(opens sec.gov)
Feb 184
Kiener Peter A0001415889-25-004529
SEC(opens sec.gov)
Jan 34
Kiener Peter A0000950170-25-001105
SEC(opens sec.gov)
Jan 44
Kiener Peter A0000950170-24-001830
SEC(opens sec.gov)
Jun 234
Kiener Peter A0001437749-23-018282
SEC(opens sec.gov)
Mar 274
Kiener Peter A0001209191-23-021201
SEC(opens sec.gov)
Jan 54
Kiener Peter A0001209191-23-001789
SEC(opens sec.gov)
Jun 244
Kiener Peter A0001583648-22-000051
SEC(opens sec.gov)
Jan 54
Kiener Peter A0000899243-22-001052
SEC(opens sec.gov)
Nov 174
Kiener Peter A0000899243-21-045070
SEC(opens sec.gov)
Jun 294
Kiener Peter A0001562180-21-004560
SEC(opens sec.gov)
Jan 64
Kiener Peter A0000899243-21-000711
SEC(opens sec.gov)

Companies

Address

C/O CUE BIOPHARMA, INC. 40 GUEST STREET

BOSTON, MA, 02135